IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Mylan Completes Acquisition of Merck’s Generics Business

1:15 PM MDT | October 17, 2007 | Chemical Week Editorial Staff

Mylan Laboratories (Canonsburg, PA) has completed the previously announced acquisition of Merck KGaA’s generic drugs business for €4.9 billion ($6.7 billion) in cash. The companies signed a definitive agreement for the deal in May (CW, May 23, p. 25). Merck’s generics business generated sales of €1.8 billion in 2006 and has about 5,000 employees. Merck previously announced that it intends to use proceeds from the sale to pay down debt. Mylan has acquired all of Merck’s generics subsidiaries worldwide, and the deal positions Mylan as...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa